An in vivo screening platform identifies senolytic compounds that target p16INK4a+ fibroblasts in lung fibrosis is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0. It has been cited 50 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01HL160895,R01HL155622
NIDDK NIH HHS
Grant: P30 DK063720
NHLBI NIH HHS
Grant: R01 HL160895
NHLBI NIH HHS
Grant: K99 HL168365
NHLBI NIH HHS
Grant: R00 HL155786
NHLBI NIH HHS
Grant: R01 HL155622
National Institutes of Health
Grant: 1R01HL155622-01
Mesenchymal modulation of epithelial metaplasia in lung fibrosis
National Institutes of Health
Grant: 1R01HL160895-01
Deciphering the role of p16INK4A+ fibroblasts in lung fibrosis
National Institutes of Health
Grant: 5P30DK063720-03
ISLET PRODUCTION FACILITY CORE
FWCI
16.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals